CS logo
small CS logo
King's Mill Hospital

Sutton in Ashfield, United Kingdom
Hospital in Sutton-in-Ashfield, England
Mansfield Rd, Sutton-in-Ashfield NG17 4JL
600 Beds

About King's Mill Hospital


King's Mill Hospital is an acute general district hospital serving the population of north Nottinghamshire and parts of Derbyshire and Lincolnshire. It is managed by the Sherwood Forest Hospitals NHS Foundation Trust.
There are 600 beds in King's Mill Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University College, London
6
University of Nottingham
5
Celgene
3
Eli Lilly and Company
2
Hoffmann-La Roche
2
Institute of Cancer Research, United Kingdom
2
Medical Research Council
2
Sherwood Forest Hospitals NHS Foundation Trust
2
Boehringer Ingelheim
1
Brynn Chappell
1
Cancer Research UK
1
Total Rows: 32

Clinical Trials at King's Mill Hospital


During the past decade, King's Mill Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years116611335511001111000044Started TrialsCompleted Trails20152016201720182019202002468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
2003-04-01
2011-07-01
Completed
580
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300
Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
2005-06-01
2009-12-01
Completed
500
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
2005-07-08
2030-12-01
Active, not recruiting
11,992
Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
2005-12-16
2024-09-01
Active, not recruiting
4,400
Prostate Adenocarcinoma TransCutaneous Hormones
2006-03-01
2021-08-01
Unknown status
2,200
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
2004-03-01
Unknown status
200
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
2006-01-01
2015-10-01
Unknown status
1,404

Rows per page:

1–48 of 48

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "King's Mill Hospital" #1 sponsor was "University College, London" with 6 trials, followed by "University of Nottingham" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 32 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "King's Mill Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Action Medical Research" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity College, London: 6University College, London: 6University of Nottingham: 5University of Nottingham: 5Celgene: 3Celgene: 3Eli Lilly and Company: 2Eli Lilly and Company: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Institute of CancerResearch, UnitedKingdom: 2Institute of CancerResearch, UnitedKingdom: 2Medical Research Council: 2Medical Research Council: 2Sherwood ForestHospitals NHSFoundation Trust: 2Sherwood ForestHospitals NHSFoundation Trust: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Brynn Chappell: 1Brynn Chappell: 1

Created with Highcharts 11.1.0Top CollaboratorsCancer Research UK: 3Cancer Research UK: 3AstraZeneca: 2AstraZeneca: 2National Institute forHealth Research, UnitedKingdom: 2National Institute forHealth Research, UnitedKingdom: 2Acceleron Pharma Inc.(a wholly ownedsubsidiary of MerckSharp and Dohme, asubsidiary of Merck &Co., Inc.): 1Acceleron Pharma Inc.(a wholly ownedsubsidiary of MerckSharp and Dohme, asubsidiary of Merck &Co., Inc.): 1Action Medical Research: 1Action Medical Research: 1Australian and NewZealand Intensive CareResearch Centre: 1Australian and NewZealand Intensive CareResearch Centre: 1Australian and NewZealand Intensive CareSociety Clinical TrialsGroup: 1Australian and NewZealand Intensive CareSociety Clinical TrialsGroup: 1Berry Consultants: 1Berry Consultants: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Global Coalition forAdaptive Research: 1Global Coalition forAdaptive Research: 1

Clinical Trials Conditions at King's Mill Hospital


According to Clinical.Site data, the most researched conditions in "King's Mill Hospital" are "Prostate Cancer" (5 trials), "Atrial Fibrillation" (3 trials), "Breast Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "King's Mill Hospital" in a lesser frequency.

Clinical Trials Intervention Types at King's Mill Hospital


Most popular intervention types in "King's Mill Hospital" are "Drug" (29 trials), "Other" (13 trials), "Device" (4 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (2 trials), "Edoxaban" (2 trials), "Luspatercept" (2 trials) and "Prednisolone" (2 trials). Other intervention names were less common.

Clinical Trials Genders at King's Mill Hospital


The vast majority of trials in "King's Mill Hospital" are 40 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at King's Mill Hospital


Currently, there are NaN active trials in "King's Mill Hospital". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in King's Mill Hospital, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in King's Mill Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 23Phase 3: 23Phase 2: 10Phase 2: 10Not Applicable: 8Not Applicable: 8Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 20Completed: 20Unknown status: 11Unknown status: 11Active, not recruiting: 7Active, not recruiting: 7Recruiting: 6Recruiting: 6Terminated: 3Terminated: 3Enrolling by invitation: 1Enrolling by invitation: 1